Definitive Contract 75N93026C00005
Award Date 6/21/26
Potential Completion Date 6/20/33
Potential Value $33M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Duke University's Office of Research Administration was awarded a $28.1 million definitive contract by the National Institute of Allergy and Infectious Diseases (NIAID) on June 21, 2019, to execute the Virology Quality Assurance (VQA) program through June 20, 2026. This is a cost-no-fee contract with no set-aside designation, performed in Durham, North Carolina. The VQA program supports external quality assurance activities for viral detection and monitoring, with particular emphasis on HIV...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $19,829,599.29 definitive cost-no-fee contract to Duke University for a Nonhuman Primate Core Humoral Immunology Laboratory to support AIDS vaccine research and development. The contract has a period of performance through March 29, 2025 and does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor for this award, which appears to be...
- This is a $6,178,859.14 federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Duke University. The contract is for a "NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT". This is a definitive, cost-no-fee contract with a period of performance through December 14, 2024. The contract was awarded on December 22, 2017 and does not have a set-aside...
- This federal contract award to Duke University was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The $13,368,236.91 definitive contract is for an "IMMUNOLOGY QUALITY ASSESSMENT PROGRAM" and does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor, and the contract has a period of performance ending on September...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $28.34 million cost-reimbursement contract to Duke University's Office of Research Administration to establish and operate the Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development. The contract, awarded on March 30, 2025, with performance through March 29, 2032, supports critical vaccine development initiatives by providing specialized laboratory services to evaluate humoral...
- This is a federal contract award to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the operation of a Virology Core Laboratory (VCL). The VCL's primary purpose is to quantitatively measure viral RNA levels in samples in support of a candidate AIDS vaccine or other intervention being tested. The contractor will also produce large volumes of well-characterized viral stocks, develop and conduct assays,...
- This is a federal contract award to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract, valued at $10,236,804.91, is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract does not have a set-aside designation. The contract is described as "TAS::75 0885::TAS", which likely refers to the task or service area, though the specific details are not provided. The...
- The National Cancer Institute (NCI) awarded a $10,586.28 firm fixed-price purchase order contract to Duke University to provide viral load assays to evaluate the levels of virus in macaques enrolled in vaccine studies. The contract has a completion date of July 7, 2025, and was awarded on July 8, 2024. Duke University's Office of Research Administration Division will be the prime contractor, and there is no set-aside designation for this award. This contract aligns with Duke's expertise in...
- This is a $2,361,452.65 federal contract award to Duke University, a private non-profit university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for a Phase 1 Clinical Trial Unit to develop therapeutics against infectious diseases. It is a delivery order placed under the Therapeutics Against Infectious Diseases Phase 1 indefinite delivery, indefinite quantity (IDIQ) contract. The contract has no...
- Duke University has been awarded a cost-no-fee task order valued at $10.38 million by the National Institutes of Health National Institute of Allergy and Infectious Diseases. The task order was issued against Duke University's existing preclinical and translational vaccine development IDIQ with the agency. Under this task order, Duke University will provide services and materials to support in vitro transcription reactions, mRNA purification, and procurement of lipid raw materials for...